SCHEMBL5847137

SCHEMBL5847137

CCCCNCCCCNCCCCNCC

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.88
CYP2C19 P33261 2/20 0.77
CYP1A2 P05177 1/20 0.77
ALDH1A1 P00352 1/20 0.71
MEN1 O00255 1/20 0.71
GLA P06280 1/20 0.71
KMT2A Q03164 1/20 0.71
KDM1A O60341 5/20 0.59
SAT1 P21673 2/20 0.50
ADH1B P00325 2/20 0.50
ADH1C P00326 2/20 0.50
ADH1A P07327 2/20 0.50
ADH7 P40394 2/20 0.50
S1PR2 O95136 5/20 0.43
S1PR4 O95977 5/20 0.43
S1PR1 P21453 5/20 0.43
S1PR3 Q99500 5/20 0.43
S1PR5 Q9H228 1/20 0.43
EPHX1 P07099 1/20 0.42
ADH4 P08319 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4166725 1.00 TSHR (0.88) TSHRCYP2C19CYP1A2ALDH1A1MEN1
SCHEMBL13895399 1.00 TSHR (0.88) TSHRCYP2C19CYP1A2ALDH1A1MEN1
SCHEMBL5319718 0.97 CYP2C19 (0.82) TSHRCYP2C19CYP1A2ALDH1A1MEN1
SCHEMBL10045115 0.97 CYP2C19 (0.82) TSHRCYP2C19CYP1A2ALDH1A1MEN1
SCHEMBL21132324 0.97 TSHR (0.82) TSHRCYP2C19CYP1A2ALDH1A1MEN1
SCHEMBL7207781 0.97 TSHR (0.82) TSHRCYP2C19CYP1A2ALDH1A1MEN1
SCHEMBL7204979 0.97 CYP2C19 (0.82) TSHRCYP2C19CYP1A2ALDH1A1MEN1
SCHEMBL7231189 0.97 TSHR (0.82) TSHRCYP2C19CYP1A2ALDH1A1MEN1
SCHEMBL11106382 0.97 TSHR (0.93) TSHRCYP2C19CYP1A2ALDH1A1MEN1
SCHEMBL31758396 0.94 TSHR (0.78) TSHRCYP2C19CYP1A2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030126-B2 Use of polyamine analogs for amyotrophic lateral sclerosis ALS THERAPY DEVELOPMENT FOUNDATION, INC. (US) 2006-04-18 US disclosed